StockData
BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

BIOREGENX, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$3.88M
P/E (TTM)
–
Dividend yield
–

BIOREGENX, INC. revenue by segment

By business segment

By product or service

RevenueQ1 26Q4 25Q3 25Q1 25Q4 24Q3 24Q1 23Q1 22% of revenueYoY
Nutritional [Member]$384.57K$377.10K$431.57K$467.53K$467.33K$496.06K––90.2%-17.7%
Medical Testing [Member]$33.82K$13.40K$58.89K$48.53K$247.86K$82.19K––7.9%-30.3%
Wellness Devices [Member]$9.80K$3.06K$17.19K$10$13.78K$16.25K––2.3%+97860.0%
Other Returns [Member]-$2.01K––-$927––––-0.5%+116.5%
Findit Services [Member]––––––$5.55K$7.70K––
Other Sales [Member]–$121$109––$1.54K––––

By region

From the segment and revenue-disaggregation notes of Bioregenx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.